Pyoderma gangrenosum - Rebel without a cure?

International Journal of Dermatology

Volumn 47, Issue 2, 2008, Pages 192-194

  Jacob, Sharon E ^a   Weisman, Robyn S ^a   Kerdel, Francisco A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Cedars Medical Center Miami   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CEFALEXIN; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DUODERM; FLUOCINONIDE; INFLIXIMAB; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYURETHAN; PREDNISONE; STEROID; TACROLIMUS; THALIDOMIDE; VANCOMYCIN; ZINC OXIDE;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FOLLOW UP; HUMAN; INFECTION; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PYODERMA GANGRENOSUM; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PYODERMA GANGRENOSUM; RECURRENCE; THALIDOMIDE; TREATMENT FAILURE;

EID: 38349181566     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03412.x     Document Type: Article

References (13)

1. Vidal D, Puig I, Gilaberte M, et al. Review of 26 cases of classical pyoderma gangrenosum: Clinical and therapeutic features. J Dermatol Treat 2004; 15: 146-152.
2. Daniels NH, Callen JP. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. Arch Dermatol 2004; 140: 1427-1429.
3. Dobson CM, Parslew RA, Evans S. Superficial granulomatous pyoderma treated with intravenous immunoglobulin. J Am Acad Dermatol 2003; 48: 456-460.
4. Federman FI, Federman DG. Recalcitrant pyoderma gangrenosum treated with thalidomide. Mayo Clin Proc 2000; 75: 842-844.
5. Kontochristopoulos GJ, Stavropoulos PG, Gregoriou S, et al. Treatment of pyoderma gangrenosum with low-dose colchicine. Dermatology 2004; 209: 233-236.
6. Sapienza MS, Cohen S, Dimarino AJ. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci 2004; 49: 1454-1457.
7. Lopez San Roman A, Bermejo F, Aldanondo I, et al. Pyoderma gangrenosum associated with ulcerative colitis: Response to infliximab. Rev Esp Enferm Dig 2004; 96: 420-424.
8. McGowan JW, Johnson CA, Lynn A. Treatment of pyoderma gangrenosum with etanercept. J Drugs Dermatol Aug 2004; 3: 441-444.
9. Baker DE. Adalimumab: Human recombinant immunoglobulin G1 anti-tumor necrosis factor monoclonal antibody. Rev Gastroenterol Disorder 2004; 4: 196-210.
10. Rau R, Simianer S, van Riel PL, et al. Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. Scand J Rheumatol 2004; 33: 145-153.
11. Sladden MJ, Mortimer NJ, Hutchinson PE. Extensive plaque psoriasis successfully treated with adalimumab (Humira). Br J Dermatol 2005; 152: 1091-1092.
12. Scheinfeld N. Adalimumab (Humira): A brief review for dermatologists. J Dermatol Treat 2004; 15: 348-352.
13. Sanchez Munoz D, Hoyas Pablos E, Ramirez Martin Del Campo M, et al. [Term pregnancy in a patient with Crohns disease under treatment with adalimumab.] Gastroenterol Hepatol 2005; 28: 435.